Rare and Unusual … Or Are They? Less Commonly Diagnosed Encephalopathies Associated with Systemic Disease

ABSTRACT

Encephalopathy due to hepatic or renal failure, electrolyte disturbances, or the administration of benzodiazepines and narcotics is commonly encountered, well reviewed in the literature, and, therefore, not usually missed. This article focuses on encephalopathies that were previously well described but may be overlooked by modern clinicians, as well as those that are still taught in the classroom but seldom thought of in practice. Due to the presumed relative rarity of these cases and emphasis on the well-memorized “classic” clinical presentations, these often treatable, and perhaps not so rare, encephalopathies due to systemic medical illness may go undiagnosed and untreated. Pancreatic encephalopathy, Wernicke's encephalopathy, and pellagra encephalopathy are reviewed in detail; cefepime and ifosfamide encephalopathies are discussed as examples of specific medication-induced encephalopathies. Septic encephalopathy, central pontine myelinolysis, and fat embolism syndrome are briefly reviewed. The encephalopathies reviewed have the potential for devastating neurological consequences if recognition and, therefore, treatment are delayed. Clinical improvement for many of these syndromes depends on prompt intervention. This article highlights some representative examples of less-commonly diagnosed metabolic and toxic encephalopathies.

KEYWORDS

Pancreatic encephalopathy - Wernicke's encephalopathy - pellagra encephalopathy

REFERENCES

• 1 Ferenci P, Lockwood A, Mullen K et al.. Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.  Hepatology. 2002;  35 716-721
• 2 Munoz S J. Hepatic encephalopathy.  Med Clin North Am. 2008;  92 795-812
• 3 Lockwood A H. Hepatic encephalopathy. In: Aminoff MJ Neurology and General Medicine. 4th ed. Philadelphia, PA; Churchill Livingstone 2008: 265-279
• 4 Morgan M Y, Blei A, Grüngreiff K et al.. The treatment of hepatic encephalopathy.  Metab Brain Dis. 2007;  22 389-405
• 5 Bleck T P. Neurological disorders in the intensive care unit.  Semin Respir Crit Care Med. 2006;  27 201-209
• 6 De Deyn P P, Saxena V K, Abts H et al.. Clinical and pathophysiological aspects of neurological complications in renal failure.  Acta Neurol Belg. 1992;  92(4) 191-206
• 7 Brouns R, De Deyn P P. Neurological complications in renal failure: a review.  Clin Neurol Neurosurg. 2004;  107 1-16
• 8 Burn D J, Bates D. Neurology and the kidney.  J Neurol Neurosurg Psychiatry. 1998;  65 810-821
• 9 Aminoff M J. Neurological dysfunction and kidney disease. In: Aminoff MJ Neurology and General Medicine. 4th ed. Philadelphia, PA; Churchill Livingstone 2008: 327-346
• 10 Riggs J E. Neurological manifestations of electrolyte disturbances.  Neurol Clin. 2002;  20(1) 227-239
• 11 Spinazzé S, Schrijvers D. Metabolic emergencies.  Crit Rev Oncol Hematol. 2006;  58 79-89
• 12 Rothermich N O, von Haam E. Pancreatic encephalopathy.  J Clin Endocrinol. 1941;  1 872-881
• 13 Estrada R V, Moreno J, Martinez E et al.. Pancreatic encephalopathy.  Acta Neurol Scand. 1979;  59 135-139
• 14 Sun G H, Yang Y S, Lui Q S, Cheng L F, Huang X S. Pancreatic encephalopathy and Wernicke encephalopathy in association with acute pancreatitis: a clinical study.  World J Gastroenterol. 2006;  12(26) 4224-4227
• 15 Ding X, Liu C A, Gong J P, Li S W. Pancreatic encephalopathy in 24 patients with severe acute pancreatitis.  Hepatobiliary Pancreat Dis Int. 2004;  3(4) 608-611
• 16 Johnson D A, Tong N T. Pancreatic encephalopathy.  South Med J. 1977;  70(2) 165-167
• 17 Ruggieri R M, Lupo I, Piccoli F. Pancreatic encephalopathy: a 7-year follow-up case report and review of the literature.  Neurol Sci. 2002;  23 203-205
• 18 Bourgeois J A, Fakhri D. Pancreatic encephalopathy with prolonged delirium.  Psychosomatics. 2007;  48(4) 352-354
• 19 Boon P, de Reuck J, Achten E, de Bleecker J. Pancreatic encephalopathy: a case report and review of the literature.  Clin Neurol Neurosurg. 1991;  93(2) 137-141
• 20 Menza M A, Murray G B. Pancreatic encephalopathy.  Biol Psychiatry. 1989;  25 781-784
• 21 Bartha P, Shifrin E, Levy Y. Pancreatic encephalopathy – a rare complication of a common disease.  Eur J Intern Med. 2006;  17 382
• 22 Sharf B, Bental E. Pancreatic encephalopathy.  J Neurol Neurosurg Psychiatry. 1971;  34 357-361
• 23 Ohkubo T, Shiojiri T, Matsunaga T. Severe diffuse white matter lesions in a patient with pancreatic encephalopathy.  J Neurol. 2004;  251(4) 476-478
• 24 Guardia S N, Bilbao J, Murray D, Warren R E, Sweet J. Fat embolism in acute pancreatitis.  Arch Pathol Lab Med. 1989;  113(5) 503-506
• 25 Vogel F S. Cerebral demyelination and focal visceral lesions in a case of acute hemorrhagic pancreatitis.  AMA Arch Pathol. 1951;  52(4) 355-362
• 26 Vogel F S. Demyelinization induced in living rabbits by means of a lipolytic enzyme preparation.  J Exp Med. 1951;  93(4) 297-304
• 27 Edmondson H A, Fields I A. Relation of calcium and lipids to acute pancreatic necrosis: report of fifteen cases, in one of which fat embolism occurred.  Arch Intern Med. 1942;  69 177-194
• 28 Sjaastad O, Gjessing S L, Ritland S, Blichfeldt P, Sandnes K. Chronic relapsing pancreatitis encephalopathy with disturbance of consciousness and CSF amino acid aberration.  J Neurol. 1979;  220(2) 83-94
• 29 Thomson A D, Cook C C, Guerrini I, Sheedy D, Harper C, Marshall E J. Wernicke's encephalopathy revisited. Translation of the case history section of the original manuscript by Carl Wernicke ‘Lehrbuch der Gehirnkrankheiten fur Aerzte and Studirende’ (1881) with a commentary.  Alcohol Alcohol. 2008;  43(2) 174-179
• 30 Pearce J MS. Wernicke-Korsakoff encephalopathy.  Eur Neurol. 2008;  59 101-104
• 31 Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management.  Lancet Neurol. 2007;  6 442-455
• 32 Victor M, Adams R D, Collins G H. The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition. 2nd ed. Philadelphia, PA; FA Davis Company 1989
• 33 Cravioto H, Korein J, Silberman J. Wernicke's encephalopathy. A clinical and pathological study of 28 autopsied cases.  Arch Neurol. 1961;  4 510-519
• 34 Harper C G, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy.  J Neurol Neurosurg Psychiatry. 1986;  49 341-345
• 35 Cook C C, Hallwood P M, Thomson A D. B vitamin deficiency and neuropsychiatric syndromes in alcohol misuse.  Alcohol Alcohol. 1998;  33(4) 317-333
• 36 Harper C. The incidence of Wernicke's encephalopathy in Australia: a neuropathological study of 131 cases.  J Neurol Neurosurg Psychiatry. 1983;  46 593-598
• 37 de Wardener H E, Lennox B. Cerebral beriberi (Wernicke's encephalopathy): review of 52 cases in a Singapore prisoner-of-war hospital.  Lancet. 1947;  1 11-17
• 38 Caine D, Halliday G M, Kril J J, Harper C G. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy.  J Neurol Neurosurg Psychiatry. 1997;  62 51-60
• 39 Wallis W E, Willoughby E, Baker P. Coma in the Wernicke-Korsakoff syndrome.  Lancet. 1978;  2(8086) 400-401
• 40 Torvik A. Brain lesions in alcoholics: neuropathological observations.  Acta Med Scand. 1987;  (suppl 717) 47-54
• 41 Thomson A D, Cook C C, Guerrini I, Sheedy D, Harper C, Marshall E J. Wernicke's encephalopathy: ‘Plus ça change, plus c'est a mème chose’.  Alcohol Alcohol. 2008;  43(2) 180-186
• 42 Alexander L. Wernicke's disease: identity of lesions produced experimentally by B₁ avitaminosis in pigeons with hemorrhagic polioencephalitis occurring in chronic alcoholism in man.  Am J Pathol. 1940;  16 61-69
• 43 Thomson A D, Marshall E J. The natural history and pathophysiology of Wernicke's encephalopathy and Korsakoff psychosis.  Alcohol Alcohol. 2006;  41(2) 151-158
• 44 Cook C CH, Thomson A D. B-complex vitamins in the prophylaxis and treatment of Wernicke-Korsakoff syndrome.  Br J Hosp Med. 1997;  57(9) 461-465
• 45 Thomson A D, Jeyasingham M D, Pratt O E, Shaw G K. Nutrition and alcoholic encephalopathies.  Acta Med Scand Suppl. 1987;  (717) 55-65
• 46 Harper C. Thiamine (vitamin B1) deficiency and associated brain damage is still common throughout the world and prevention is simple and safe!.  Eur J Neurol. 2006;  13 1078-1082
• 47 Todd K G, Hazell A S, Butterworth R F. Alcohol-thiamine interactions: an update on the pathogenesis of Wernicke encephalopathy.  Addict Biol. 1999;  4 261-272
• 48 Thomson A D, Cook C C, Touquet R, Henry J A. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the accident and emergency department.  Alcohol Alcohol. 2002;  37(6) 513-521
• 49 Meyer O. The Wernicke syndrome: with special reference to manic syndromes associated with hypothalamic lesions.  J Neurol Neurosurg Psychiatry. 1944;  7 66-75
• 50 Spruill S C, Kuller J A. Hyperemesis gravidarum complicated by Wernicke's encephalopathy.  Obstet Gynecol. 2002;  99(5) 875-877
• 51 Salas-Salvadó J, García-Lorda P, Cuatrecasas G et al.. Wernicke's syndrome after bariatric surgery.  Clin Nutr. 2000;  19(5) 371-373
• 52 Juhasz-Pocsine K, Rudnicki S A, Archer R L, Harik S I. Neurological complications of gastric bypass surgery for morbid obesity.  Neurology. 2007;  68 1843-1850
• 53 Wrenn K D, Slovis C M. Is intravenous thiamine safe?.  Am J Emerg Med. 1992;  10(2) 165
• 54 Bae S J, Lee H K, Lee J H, Choi C G, Suh D C. Wernicke's encephalopathy: atypical manifestation at MR imaging.  AJNR Am J Neuroradiol. 2001;  22 1480-1482
• 55 Koontz D W, Fernandes Filho J A, Sagar S M, Rucker J C. Video: Wernicke encephalopathy.  Neurology. 2004;  63(2) 394
• 56 Day E, Bentham B, Callaghan R, Kuruvilla T, George S. Thiamine for Wernicke-Korsakoff syndrome in people at risk from alcohol abuse.  Cochrane Database Syst Rev. 2004;  1 CD004033
• 57 Rajakumar K. Pellagra in the United States: a historical perspective.  South Med J. 2000;  93(3) 272-277
• 58 Lanska D J. Stages in the recognition of epidemic pellagra in the United States: 1865–1960.  Neurology. 1996;  47 829-834
• 59 Spivak J L, Jackson D L. Pellagra: an analysis of 18 patients and a review of the literature.  Johns Hopkins Med J. 1977;  140 295-309
• 60 Figueroa W G, Sargent F, Imperiale L et al.. Lack of avitaminosis among alcoholics: its relation to fortification of cereal products and the general nutritional status of the population.  J Clin Nutr. 1953;  1(3) 179-199
• 61 Kertesz S G. Pellagra in 2 homeless men.  Mayo Clin Proc. 2001;  76 315-318
• 62 Jarrett P, Duffill M, Oakley A, Smith A. Pellagra, azathioprine and inflammatory bowel disease.  Clin Exp Dermatol. 1997;  22 44-45
• 63 Lyon V B, Fairley J A. Anticonvulsant-induced pellagra.  J Am Acad Dermatol. 2002;  46 597-599
• 64 Isaac S. The “gauntlet” of pellagra.  Int J Dermatol. 1998;  37 599
• 65 MacDonald A, Forsyth A. Nutritional deficiencies and the skin.  Clin Exp Dermatol. 2005;  30 388-390
• 66 Jagielska G, Tomaszewicz-Libudzic C E, Brzozowska A. Pellagra: a rare complication of anorexia nervosa.  Eur Child Adolesc Psychiatry. 2007;  16 417-420
• 67 Itami A, Ando I, Kukita A, Nagai K. Pellagra associated with amyloidosis secondary to multiple myeloma.  Br J Dermatol. 1997;  137 829
• 68 Delgado-Sanchez L, Godkar D, Niranjan S. Pellagra: rekindling of an old flame.  Am J Ther. 2008;  15 173-175
• 69 Okan G, Yaylaci S, Alzafer S. Pellagra: will we see it more frequently?. J Eur Acad Dermatol Venereol 2008; June 26 (Epub ahead of print) Available at: http://www3.interscience.wiley.com/journal/120748368\abstract Accessed August 3, 2008
• 70 Ishii N, Nishihara Y. Pellagra among chronic alcoholics: clinical and pathological study of 20 necropsy cases.  J Neurol Neurosurg Psychiatry. 1981;  44 209-215
• 71 Spies T D, Aring C D, Gelperin J, Bean W B. The mental symptoms of pellagra: their relief with nicotinic acid.  Am J Med Sci. 1938;  196(4) 461-475
• 72 Piercecchi-Marti M D, Pélissier-Alicot A L, Leonetti G, Tervé J P, Cianfarani F, Pellissier J F. Pellagra: a rare disease observed in a victim of mental and physical abuse.  Am J Forensic Med Pathol. 2004;  25(4) 342-344
• 73 Serdaru M, Hausser-Hauw C, Laplane D et al.. The clinical spectrum of alcoholic pellagra encephalopathy: a retrospective analysis of 22 cases studied pathologically.  Brain. 1988;  111 829-842
• 74 Ishii N, Nishihara Y. Pellagra encephalopathy among tuberculous patients: its relation to isoniazid therapy.  J Neurol Neurosurg Psychiatry. 1985;  48 628-634
• 75 Zimmerman H M, Cohen L H, Gildea E F. Pellagra in association with chronic alcoholism.  Arch Neurol Psychiatry. 1934;  31 290-309
• 76 Jolliffe N, Bowman K M, Rosenblum L A, Fein H D. Nicotinic acid deficiency encephalopathy.  JAMA. 1941;  114 307-312
• 77 Jolliffe N. Treatment of neuropsychiatric disorders with vitamins.  JAMA. 1941;  117 1496-1502
• 78 Victor M. Alcoholic dementia.  Can J Neurol Sci. 1994;  21 88-99
• 79 Langworthy O R. Lesions of the central nervous system characteristic of pellagra.  Brain. 1931;  54 291-302
• 80 Pitsavas S, Andreou C, Bascialla F, Bozikas V P, Karavatos A. Pellagra encephalopathy following B-complex vitamin treatment without Niacin.  Int J Psychiatry Med. 2004;  34(1) 91-95
• 81 Spies T D, DeWolf H F. Observations on the etiological relationship of severe alcoholism to pellagra.  Am J Med Sci. 1933;  186(4) 521-525
• 82 Lu J Y, Yu C L, Wu M Z. Pellagra in an immunocompetent patient with cytomegalovirus colitis.  Am J Gastroenterol. 2001;  96(3) 932-934
• 83 Wallengren J, Thelin I. Pellagra-like skin lesions associated with Wernicke's encephalopathy in a heavy wine drinker.  Acta Derm Venereol. 2002;  82 152-154
• 84 Lishman W A. Cerebral disorder in alcoholism: syndromes of impairment.  Brain. 1981;  104 1-20
• 85 Pandharipande P, Shintani A, Peterson J et al.. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients.  Anesthesiology. 2006;  104 21-26
• 86 Alagiakrishnan K, Wiens C A. An approach to drug induced delirium in the elderly.  Postgrad Med J. 2004;  80 388-393
• 87 Marcantonio E R, Juarez G, Goldman L et al.. The relationship of postoperative delirium with psychoactive medications.  JAMA. 1994;  272(19) 1518-1522
• 88 Barradell L B, Bryson H M. Cefepime: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use.  Drugs. 1994;  47(3) 471-505
• 89 Diekema D J, Pfaller M A, Schmitz F J et al.. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for SENTRY antimicrobial surveillance program, 1997–1999.  Clin Infect Dis. 2001;  32(suppl 2) S114-S132
• 90 Diekema D J, Pfaller M A, Jones R N et al.. Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997.  Clin Infect Dis. 1999;  29(3) 595-607
• 91 Neu H C. Safety of cefepime: a new extended-spectrum parenteral cephalosporin.  Am J Med. 1996;  100(suppl 6A) 68S-75S
• 92 Lam S, Gomolin I H. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review.  Pharmacotherapy. 2006;  26(8) 1169-1174
• 93 Jallon P, Fankhauser L, Du Pasquier R et al.. Severe but reversible encephalopathy associated with cefepime.  Neurophysiol Clin. 2000;  30 383-386
• 94 Fishbain J T, Monahan T P, Canonico M M. Cerebral manifestations of cefepime toxicity in a dialysis patient.  Neurology. 2000;  55(1) 1756-1757
• 95 Dixit S, Kurle P, Buyan-Dent L, Sheth R D. Status epilepticus associated with cefepime.  Neurology. 2000;  54 2153-2155
• 96 Martínez-Rodríguez J E, Barriga F J, Santamaria J et al.. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure.  Am J Med. 2001;  111 115-119
• 97 Fernández-Torre J L, Martínez-Martínez M, González-Rato J et al.. Cephalosporin-induced nonconvulsive status epilepticus: clinical and electroencephalographic features.  Epilepsia. 2005;  46(9) 1550-1552
• 98 Barbey F, Bugnon D, Wauters J P. Severe neurotoxicity of cefepime in uremic patients.  Ann Intern Med. 2001;  135(11) 1011
• 99 De Silva D A, Pan A B, Lim S H. Cefepime-induced encephalopathy with triphasic waves in three Asian patients.  Ann Acad Med Singapore. 2007;  36(6) 450-451
• 100 Chatellier D, Jourdain M, Mangalaboyi J et al.. Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure.  Intensive Care Med. 2002;  28 214-217
• 101 Capparelli F J, Diaz M F, Hlavnika A et al.. Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function.  Neurology. 2005;  65(11) 1840
• 102 Maganti R, Jolin D, Rishi D, Biswas A. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function.  Epilepsy Behav. 2006;  8 312-314
• 103 Fishman R A. Blood-brain and CSF barriers to penicillin and related organic acids.  Arch Neurol. 1966;  15 113-124
• 104 Abanades S, Nolla J, Rodríguez-Campello A, Pedro C, Valls A, Farré M. Reversible coma secondary to cefepime neurotoxicity.  Ann Pharmacother. 2004;  38 606-608
• 105 Fernández-Torre J L. Cefepime and cefixime-induced encephalopathy in a patient with normal renal function.  , (Letter to Editor) Neurology. 2006;  67(2) 367
• 106 Capparelli F J, Diaz M F, Hlavnika A, Wainsztein N A, Leiguarda R, Del Castillo M E. Cefepime and cefixime-induced encephalopathy in a patient with normal renal function.  , (Reply from authors) Neurology. 2006;  67(2) 367
• 107 De Sarro A, Ammendola D, Zappala M, Grasso S, De Sarro G B. Relationship between structure and convulsant properties of some β-lactam antibiotics following intracerebroventricular microinjection in rats.  Antimicrob Agents Chemother. 1995;  39(1) 232-237
• 108 Sugimoto M, Uchida I, Mashimo T et al.. Evidence for the involvement of GABA_A receptor blockade in convulsions induced by cephalosporins.  Neuropharmacology. 2003;  45 304-314
• 109 Streck E L, Comim C M, Barichello T, Quevedo J. The septic brain.  Neurochem Res. 2008;  33(11) 2171-2177
• 110 Dakdouki G K, Al-Awar G N. Cefepime-induced encephalopathy.  Int J Infect Dis. 2004;  8 59-61
• 111 Jackson G D, Berkovic S F. Ceftazidime encephalopathy: absence status and toxic hallucinations.  J Neurol Neurosurg Psychiatry. 1992;  55(4) 333-334
• 112 Kiangkitiwan B, Doppalapudi A, Fonder M, Solberg K, Bohner B. Levofloxacin-induced delirium with psychotic features.  Gen Hosp Psychiatry. 2008;  30 381-383
• 113 Isaacson S H, Carr J, Rowan A J. Ciprofloxacin-induced complex partial status epilepticus manifesting as an acute confusional state.  Neurology. 1993;  43 1619-1621
• 114 Park I S, Lee H J, Lee Y S, Hwang J S, Lee M S. Ifosfamide-induced encephalopathy with or without using methylene blue.  Int J Gynecol Cancer. 2005;  15 807-810
• 115 David K A, Picus J. Evaluating risk factors for the development of ifosfamide encephalopathy.  Am J Clin Oncol. 2005;  28(3) 277-280
• 116 Patel P N. Methylene blue for management of ifosfamide-induced encephalopathy.  Ann Pharmacother. 2006;  40 299-303
• 117 Pelgrims J, De Vos F, Van den Brande J, Schrijvers D, Prové A, Vermorken J B. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.  Br J Cancer. 2000;  82(2) 291-294
• 118 Buesa J M, García-Teijido P, Losa R, Fra J. Treatment of ifosfamide encephalopathy with intravenous thiamin.  Clin Cancer Res. 2003;  9 4636-4637
• 119 Simonian N A, Gilliam F G, Chiappa K H. Ifosfamide causes a diazepam-sensitive encephalopathy.  Neurology. 1993;  43 2700-2702
• 120 Papadopoulos M C, Ceri Davies D, Moss R F, Tighe D, Bennett E D. Pathophysiology of septic encephalopathy: a review.  Crit Care Med. 2000;  28(8) 3019-3024
• 121 Young G B. Neurologic complications of systemic critical illness.  Neurol Clin. 1995;  13(3) 645-658
• 122 Bolton C F, Young G B, Zochodne D W. The neurological complications of sepsis.  Ann Neurol. 1993;  33 94-100
• 123 Young G B, Bolton C F, Archibald Y M, Austin T W, Wells G A. The electroencephalogram in sepsis-associated encephalopathy.  J Clin Neurophysiol. 1992;  9(1) 145-152
• 124 van der Helm-van Mil A H, van Vugt J PP, Lammers G J, Harinck H I. Hypernatremia from a hunger strike as a cause of osmotic myelinosis.  Neurology. 2005;  64(1) 574-575
• 125 Kleinschmidt-DeMasters B K, Rojiani A M, Filley C M. Central and extrapontine myelinolysis: then…and now.  J Neuropathol Exp Neurol. 2006;  65(1) 1-11
• 126 Talbot M, Schemitsch E H. Fat embolism syndrome: history, definition, epidemiology.  Injury. 2006;  37(S4) S3-S7
• 127 Fabian T C. Unraveling the fat embolism syndrome.  N Engl J Med. 1993;  329 961-963
• 128 Wang H D, Zheng J H, Deng C L, Liu Q Y, Yang S L. Fat embolism syndromes following liposuction.  Aesthetic Plast Surg. 2008;  32(5) 731-736
• 129 Jacobson D M, Terrence C F, Reinmuth O M. The neurologic manifestations of fat embolism.  Neurology. 1986;  36(6) 847-851
• 130 Hüfner K, Holtmannspötter M, Bürkle H et al.. Fat embolism syndrome as a neurologic emergency.  Arch Neurol. 2008;  65(8) 1124-1125
• 131 Van Besouw J P, Hinds C J. Fat embolism syndrome.  Br J Hosp Med. 1989;  42(4) 304-311
• 132 Parizel P M, Demey H E, Veeckmans G et al.. Early diagnosis of cerebral fat embolism syndrome by diffusion-weighted MRI (starfield pattern).  Stroke. 2001;  32 2942-2944